Article citationsMore>>

Nagata, T., Fukuzawa, T., Takeda, M., Fukazawa, M., Mori, T., Nihei, T., Honda, K., Suzuki, Y. and Kawabe, Y. (2013) Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db/db mice. British Journal of Pharmacology, 170, 519-531. http://dx.doi.org/10.1111/bph.12269

has been cited by the following article:

• TITLE: Diabetic mouse models

  AUTHORS: Yoshiaki Katsuda, Takeshi Ohta, Masami Shinohara, Tong Bin, Takahisa Yamada

  KEYWORDS: Diabetes; Diabetic Complication; Mouse Model; Obesity

  JOURNAL NAME: Open Journal of Animal Sciences, Vol.3 No.4, November 20, 2013

  ABSTRACT: The number of patients with lifestyle-related diseases, such as cardiovascular disease, diabetes mellitus, hypertension, atherosclerosis, and cancer, is increasing all over the world, and that of diabetics is increasing especially rapidly. Diabetic animal models have played a key role in elucidating the etiology of diabetes and developing anti-diabetic drugs. In this review, we overviewed characteristics of diabetic mouse models and pharmacological evaluation using the diabetic models.